Published in J Clin Lab Anal on January 01, 1992
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci U S A (1993) 6.44
Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med (1996) 3.87
Feeding of western gray whales during a seismic survey near Sakhalin Island, Russia. Environ Monit Assess (2007) 3.46
Distribution and abundance of western gray whales during a seismic survey near Sakhalin Island, Russia. Environ Monit Assess (2007) 3.25
Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (1997) 2.41
Selective loss of suppressor cell function in New Zealand mice induced by NTA. J Immunol (1977) 2.38
Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev (1988) 1.78
Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol (1985) 1.52
Sex differences in formation of anti-T-cell antibodies. Nature (1976) 1.30
Detection of cytomegalovirus by 24-well plate centrifugation assay using a monoclonal antibody to an early nuclear antigen and by conventional cell culture. J Virol Methods (1987) 1.29
Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med (1978) 1.26
Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology (1996) 1.25
Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev (1991) 1.19
Ribavirin: efficacy in the treatment of murine autoimmune disease. Science (1977) 1.15
HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments. Ann Rheum Dis (1998) 1.14
Genetic studies in NZB mice. I. Spontaneous autoantibody production. J Exp Med (1978) 1.13
Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. Arthritis Rheum (1999) 1.10
Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum (2001) 1.09
Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochem Pharmacol (2001) 1.08
Biochemistry of Coxiella burnetii: 6-phosphogluconic acid dehydrogenase. J Bacteriol (1970) 1.06
Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology (2000) 1.06
Influence of human development and predators on nest survival of tundra birds, Arctic Coastal Plain, Alaska. Ecol Appl (2009) 1.05
Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay. Chem Res Toxicol (1997) 1.04
Role of suppressor T cells in lymphopoietic disorders. Clin Haematol (1977) 1.02
Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury. Atherosclerosis (1998) 1.01
Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus. Immunology (1983) 0.99
Studies on levamisole--induced agranulocytosis. Blood (1980) 0.98
Biochemistry of Coxiella burnetii: Embden-Meyerhof pathway. J Bacteriol (1971) 0.97
Immunofluorescence studies of anti-T cell antibodies and T cells in systemic lupus erythematosus. Selective loss of brightly staining T cells in active disease. Arthritis Rheum (1979) 0.97
Hypoxia-induced thrombocytopenia in mice. J Lab Clin Med (1975) 0.97
Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-alpha. Clin Immunol Immunopathol (1990) 0.96
Adenovirus infection in patients with Kawasaki disease. J Med Virol (1990) 0.94
Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed rats. Gastroenterology (1998) 0.93
Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone. Clin Exp Immunol (1992) 0.92
IgG subclasses in gingival crevicular fluid from active versus stable periodontal sites. J Periodontol (1989) 0.91
Substance P increases neutrophil adhesion to bronchial epithelial cells. J Immunol (1994) 0.90
Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant. Alcohol Clin Exp Res (1998) 0.90
Adenovirus type-2 in a patient with lethal hemorrhagic colonic ulcers and chronic active Epstein-Barr virus infection. Ann Intern Med (1988) 0.89
Isolation and characterization of circulating immune complexes from patients with pneumococcal pneumonia. Infect Immun (1987) 0.88
Experimental medullary aplasia. J Lab Clin Med (1972) 0.88
In situ lymphocyte subpopulations from active versus stable periodontal sites. J Periodontol (1988) 0.88
Elucidation of reaction scheme describing malondialdehyde-acetaldehyde-protein adduct formation. Chem Res Toxicol (2001) 0.87
Method for the isolation of bacteriphage T4 mutants that produce particles with giant capsids. J Virol (1976) 0.87
Glucosylated collagen is antigenic. Diabetes (1983) 0.87
Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease. Gastroenterology (1992) 0.86
Comparison of serum amyloid A and C-reactive protein as indicators of lung inflammation in corticosteroid treated and non-corticosteroid treated cystic fibrosis patients. J Clin Lab Anal (1992) 0.86
Circulating immune complexes in cystic fibrosis and their correlation to clinical parameters. Pediatr Res (1986) 0.86
Effect of the anti-estrogen, Nafoxidine, on NZB/W autoimmune disease. Arthritis Rheum (1978) 0.85
Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice. Immunology (1982) 0.85
Graft versus host disease following transfusion of normal blood products to patients with malignancies. J Surg Oncol (1987) 0.84
The chemistry and biological effects of malondialdehyde-acetaldehyde adducts. Alcohol Clin Exp Res (2001) 0.84
Ribavirin treatment in murine autoimmune disease. I. Therapeutic efficacy and effect on the immune response. Arthritis Rheum (1979) 0.83
Infectious bursal disease virus: further characterization with evidence for a single-stranded RNA virus. Avian Dis (1981) 0.83
Serum selenium concentrations in rheumatoid arthritis. Ann Rheum Dis (1991) 0.82
Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans. Anesth Analg (1994) 0.82
Therapeutic studies in NZB/NZW mice. VI. Age-dependent effects of concanavalin A stimulated spleen cell supernate. Arthritis Rheum (1978) 0.82
Immune mechanisms of alcohol-induced liver disease. Hepatology (1995) 0.82
Host response to infection by Coxiella burneti. Can J Microbiol (1975) 0.82
Familial canine dermatomyositis: clinicopathologic, immunologic, and serologic studies. Am J Vet Res (1985) 0.81
Acute graft-versus-host disease resulting from normal donor blood transfusions. Acta Haematol (1984) 0.81
Isolation of immune complexes by an equine Clq-like factor. Immunol Commun (1981) 0.81
Purification of the subunit Clq from the first component of equine complement. Immunology (1979) 0.81
Testicular shielding in low-dose total body irradiation. Bone Marrow Transplant (2007) 0.81
Isolation and quantitation of immune complexes in diabetic syrian hamsters: a chronological study. J Clin Lab Immunol (1983) 0.81
The use of outcome measures to evaluate clinical rheumatology curriculum changes. J Rheumatol (1993) 0.81
Effect of high-dose cyclophosphamide and total-body irradiation on left ventricular function in adult patients with leukemia undergoing allogeneic bone marrow transplantation. Cancer Treat Rep (1986) 0.81
Cytomegalovirus cecal erosion causing massive hemorrhage in a bone marrow transplant recipient. World J Surg (1982) 0.81
Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate. J Rheumatol Suppl (1996) 0.80
Human herpesvirus 6 infection and Kawasaki disease. J Clin Microbiol (1989) 0.80
Glomerular injury in end-stage liver disease--role of circulating IgG and IgM immune complexes. Pediatr Nephrol (1993) 0.80
Protein modification in ethanol toxicity. Adverse Drug React Toxicol Rev (2001) 0.80
Modulation of neutrophil and mononuclear cell adherence to bronchial epithelial cells. Am J Respir Cell Mol Biol (1992) 0.80
Study of the multiple factors in the pathogenesis of autoimmunity in New Zealand mice. Arthritis Rheum (1978) 0.79
Bronchial epithelial cells release chemotactic activity for lymphocytes. Am J Physiol (1989) 0.79
Isolation of virus and antibody containing immune complexes from mink with Aleutian disease by affinity chromatography of equine complement clq. Am J Vet Res (1983) 0.79
Interferon-gamma in a family with X-linked lymphoproliferative syndrome with acute Epstein-Barr virus infection. J Clin Immunol (1989) 0.79
Nosocomial Legionnaires' disease. Occurrence in recipients of bone marrow transplants. Am J Med (1983) 0.79
Interaction between canine platelets and adult heartworms: platelet recognition of heartworm surfaces. Am J Vet Res (1986) 0.78
In situ activated T lymphocytes in active versus stable periodontal lesions. J Periodontal Res (1988) 0.78
Selenium and the immune response: 2. Enhancement of murine cytotoxic T-lymphocyte and natural killer cell cytotoxicity in vivo. J Leukoc Biol (1989) 0.78
Prospective study of familial canine dermatomyositis. Correlation of the severity of dermatomyositis and circulating immune complex levels. Am J Pathol (1986) 0.78
Severe chronic active Epstein-Barr virus infection syndrome and adenovirus type-2 infection. Am J Pediatr Hematol Oncol (1990) 0.78
Use of ethanol-eluted hydrophobic interaction chromatography in the purification of serum amyloid A. Protein Expr Purif (1992) 0.78
Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation, and autologous marrow transplantation for refractory lymphoma. Cancer Treat Rep (1986) 0.78
Improved survival in murine lupus as the result of selenium supplementation. Clin Exp Immunol (1988) 0.78
Toxicity of purothionin and its homologues to the tobacco hornworm, Manduca sexta (L.) (Lepidoptera:Sphingidae). Toxicol Appl Pharmacol (1979) 0.77
Comparison of antibody isotypes in sera and circulating immune complexes during tumor growth and metastasis of three tumor models in mice. Cancer Res (1984) 0.77
Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation. Curr Mol Med (2015) 0.77
Toxic shock syndrome: a retrospective study of 25 cases from Iowa. Am J Med Sci (1982) 0.77
Monoclonal and polyclonal antibodies recognizing acetaldehyde-protein adducts. Biochem Pharmacol (1998) 0.77
Long-term ethanol administration alters the degradation of acetaldehyde adducts by liver endothelial cells. Hepatology (1996) 0.77
Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex. J Natl Cancer Inst (1983) 0.77